P2X1 receptors and the endothelium

Memorias do Instituto Oswaldo Cruz

Volumn 100, Issue SUPPL. 1, 2005, Pages 111-112

  Harrington, L S ^a   Mitchell, J A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Adenosine triphosphate; Endothelium; P2X1 receptor; Smooth muscle cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; LIGAND; PURINE P2X RECEPTOR; PURINE P2X1 RECEPTOR; PURINE P2Y RECEPTOR; VASOACTIVE AGENT; PURINE P2 RECEPTOR;

ARTERY; BLOOD VESSEL REACTIVITY; CONFERENCE PAPER; ENDOTHELIUM; MEDIATOR; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION; ARTICLE; CYTOLOGY; ENZYMOLOGY; HUMAN; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ADENOSINE TRIPHOSPHATE; ENDOTHELIUM, VASCULAR; HUMANS; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, PURINERGIC P2; VASODILATION;

EID: 18844432548     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762005000900019     Document Type: Conference Paper

References (24)

1. Boeynaems JM, Communi D, Savi P, Herbert JM 2000. P2Y receptors: in the middle of the road. Trends Pharmacol Sci 21: 1-3.
2. Burnstock G 1999. Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 194 (Pt 3): 335-342.
3. Burnstock G, Kennedy C 1985. Is there a basis for distinguishing two types of P2 purinoceptor? Gen Pharmacol 16: 433-440.
4. Conigrave AD, Fernando KC, Gu B, Tasevski V, Zhang W, Luttrell BM, Wiley JS 2001. P2Y(11) receptor expression by human lymphocytes: evidence for two cAMP-linked purinoceptors. Eur J Pharmacol 426: 157-163.
5. Glass R, Loesch A, Bodin P, Burnstock G 2002. P2X4 and P2X6 receptors associate with VE-cadherin in human endothelial cells. Cell Mol Life Sci 59: 870-881.
6. Harrington LS, Mitchell JA 2004. Novel role for P2X receptor activation in endothelium-dependent vasodilation. Br J Pharm 143: 611-617.
7. Hansen MA, Dutton JL, Balcar VJ, Barden JA, Bennett MR 1999. P2X (purinergic) receptor distributions in rat blood vessels. J Auton Nerv Syst 75: 147-155.
8. Knight GE, Oliver-Redgate R, Burnstock G 2003. Unusual absence of endothelium-dependant or -independent vasodilatation to purines or pyrimidines in the rat renal artery. Kidney Int 64: 1389-1397.
9. Kunapuli SP, Daniel JL 1998. P2 receptor subtypes in the cardiovascular system. Biochem J 336 (Pt 3): 513-523.
10. Lewis CJ, Evans RJ 2000. Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels. Br J Pharmacol 131: 1659-1666.
11. Malmsjo M, Chu ZM, Croft K, Erlinge D, Edvinsson L, Beilin LJ 2002. P2Y receptor-induced EDHF vasodilatation is of primary importance for the regulation of perfusion pressure in the peripheral circulation of the rat. Acta Physiol Scand 174: 301-309.
12. North RA 2002. Molecular physiology of P2X receptors. Physiol Rev 82: 1013-1067.
13. Ralevic V 2002. The involvement of smooth muscle P2X receptors in the prolonged vasorelaxation response to purine nucleotides in the rat mesenteric arterial bed. Br J Pharmacol 135: 1988-1994.
14. Ralevic V, Burnstock G 1988. Actions mediated by P2-purinoceptor subtypes in the isolated perfused mesenteric bed of the rat. Br J Pharmacol 95: 637-645.
15. Ralevic V, Burnstock G 1991. Effects of purines and pyrimidines on the rat mesenteric arterial bed. Circ Res 69: 1583-1590.
16. Ray FR, Huang W, Slater M, Barden JA 2002. Purinergic receptor distribution in endothelial cells in blood vessels: a basis for selection of coronary artery grafts. Atherosclerosis 162: 55-61.
17. Simon J, Webb TE, King BF, Burnstock G, Barnard EA 1995. Characterisation of a recombinant P2Y purinoceptor. Eur J Pharmacol 291: 281-289.
18. Stanford SJ, Gitlin JM, Mitchell JA 2001. Identification of two distinct vasodilator pathways activated by ATP in the mesenteric bed of the rat. Br J Pharmacol 133: 825-832.
19. Surprenant A, Schneider DA, Wilson HL, Galligan JJ, North RA 2000. Functional properties of heteromeric P2X(1/5) receptors expressed in HEK cells and excitatory junction potentials in guinea-pig submucosal arterioles. J Auton Nerv Syst 81: 249-263.
20. van der WL, Adams DJ, Luttrell BM, Conigrave AD, Morris MB 2000. Pharmacological characterisation of the P2Y11 receptor in stably transfected haematological cell lines. Mol Cell Biochem 213: 75-81.
21. Virginio C, Robertson G, Surprenant A, North RA 1998. Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2/3 receptors. Mol Pharmacol 53: 969-973.
22. Yamamoto K, Korenaga R, Kamiya A, Qi Z, Sokabe M, Ando J 2000. P2X(4) receptors mediate ATP-induced calcium influx in human vascular endothelial cells. Am J Physiol Heart Circ Physiol 279: H285-H292.
23. Yang S, CheekDJ, Westfall DP, Buxton IL 1994. Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells. Circ Res 74: 401-407.
24. Zimmermann H 2000. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362: 299-309.